In a recent study Nik-Zainal et al. 12 described a distinct profile (which they termed profile D) of substitutions and deletions in breast cancer with BRCA1/2 mutations, which later was reported by Alexandrov et al. 11 as signature 3 in a pan-cancer analysis. This evidence concerns the gene BRCA1 and breast carcinoma.